Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/215736
Title: | Risk factors associated with blood transfusion in liver transplantation |
Author: | Pérez, Lourdes Sabaté Pes, Antoni, Gutierrez, Rosa Caballero Milán, Marta Pujol, Roger Llaurado, Sandra Peñafiel, Judith Hereu, Pilar Blasi Ibáñez, Annabel |
Keywords: | Transfusió de sang Trasplantament hepàtic Blood transfusion Hepatic transplantation |
Issue Date: | 16-Aug-2024 |
Publisher: | Springer Science and Business Media LLC |
Abstract: | To explore preoperative and operative risk factors for red blood cell (RBC) transfusion requirements during liver transplantation (LT) and up to 24 h afterwards. We evaluated the associations between risk factors and units of RBC transfused in 176 LT patients using a log-binomial regression model. Relative risk was adjusted for age, sex, and the model for end-stage liver disease score (MELD) (adjustment 1) and baseline hemoglobin concentration (adjustment 2). Forty-six patients (26.14%) did not receive transfusion. Grafts from cardiac-death donors were used in 32.61% and 31.54% of non-transfused and transfused patients, respectively. The transfused group required more reoperation for bleeding (P = 0.035), longer mechanical ventilation after LT (P < 0.001), and longer ICU length of stay (P < 0.001). MELD and hemoglobin concentrations determined RBC requirements. For each unit of increase in the MELD score, 2% more RBC units were transfused, and non-transfusion was 0.83-fold less likely. For each 10-g/L higher hemoglobin concentration at baseline, 16% less RBC transfused, and non-transfusion was 1.95-fold more likely. Ascites was associated with 26% more RBC transfusions. With an increase of 2 mm from the baseline in the A10Fibtem measurement of maximum clot firmness, non-transfusion was 1.14-fold more likely. A 10-min longer cold ischemia time was associated with 1% more RBC units transfused, and the presence of post-reperfusion syndrome with 45% more RBC units. We conclude that preoperative correction of anemia should be included in LT. An intervention to prevent severe hypotension and fibrinolysis during graft reperfusion should be explored. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41598-024-70078-2 |
It is part of: | Scientific Reports, 2024, vol. 14, num. 1 |
URI: | https://hdl.handle.net/2445/215736 |
Related resource: | https://doi.org/10.1038/s41598-024-70078-2 |
ISSN: | 2045-2322 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s41598-024-70078-2.pdf | 1.03 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License